These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35434762)

  • 1. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Adv Ther; 2024 Jun; 41(6):2168-2195. PubMed ID: 38683294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):758-780. PubMed ID: 34918367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
    Abdel-Maboud M; Menshawy A; Hasabo EA; Abdelraoof MI; Alshandidy M; Eid M; Menshawy E; Outani O; Menshawy A
    PLoS One; 2021; 16(7):e0254412. PubMed ID: 34280195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.
    Huang R; Zhao PF; Xu JH; Liu DD; Luo FD; Dai YH
    J Cell Biochem; 2018 Mar; 119(3):2501-2511. PubMed ID: 28941255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
    EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atorvastatin on testosterone levels.
    Shawish MI; Bagheri B; Musini VM; Adams SP; Wright JM
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013211. PubMed ID: 33482034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Ther Adv Endocrinol Metab; 2022; 13():20420188221127142. PubMed ID: 36225721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pharmacological interventions on lipid profiles and C-reactive protein in polycystic ovary syndrome: A systematic review and meta-analysis.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Clin Endocrinol (Oxf); 2022 Apr; 96(4):443-459. PubMed ID: 34779013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
    Liao M; Li X; Zhang H; Zhou L; Shi L; Li W; Shen R; Peng G; Zhao H; Shao J; Wang X; Sun Z; Zheng H; Long M
    Endocrine; 2024 Jan; 83(1):227-241. PubMed ID: 37653215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
    Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Clin Endocrinol (Oxf); 2022 Mar; 96(3):371-394. PubMed ID: 34713480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
    van Zuuren EJ; Fedorowicz Z
    Br J Dermatol; 2016 Jul; 175(1):45-61. PubMed ID: 26892495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
    Amiri M; Kabir A; Nahidi F; Shekofteh M; Ramezani Tehrani F
    Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):64-77. PubMed ID: 29457756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
    Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e817-e836. PubMed ID: 37554096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
    Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
    BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Shamasbi SG; Ghanbari-Homayi S; Mirghafourvand M
    Eur J Nutr; 2020 Mar; 59(2):433-450. PubMed ID: 31256251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.